Effect of transjugular intrahepatic portosystemic shunt on glycometabolism in cirrhosis patients

Clinics and Research in Hepatology and Gastroenterology

Volumn 36, Issue 1, 2012, Pages 53-59

  Su, An Ping ^a   Cao, Shuang Shuang ^a   Le Tian, Bo ^a   Da Zhang, Zhao ^a   Hu, Wei Ming ^a   Zhang, Yi ^a   Wang, Zheng Liang ^a   Babu, Shah Ram ^a   Hu, Tao ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C PEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD FLOW; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART OUTPUT; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERGLUCAGONEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PORTAL VEIN BLOOD PRESSURE; PROTEIN BLOOD LEVEL; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

ADULT; AGED; ALGORITHMS; CARDIAC OUTPUT; CASE-CONTROL STUDIES; DIABETES MELLITUS; FEMALE; GLUCAGON; GLUCOSE TOLERANCE TEST; HORMONES; HUMANS; HYPERINSULINISM; HYPERTENSION, PORTAL; INSULIN RESISTANCE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; POSTOPERATIVE CARE; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84856713644     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2011.09.011     Document Type: Article

References (29)

1. Garcia-Tsao G., Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 2010, 362:823-832.
2. Groszmann R.J., Bosch J., Grace N.D., Conn H.O., Garcia-Tsao G., Navasa M., et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990, 99:1401-1407.
3. Powell W.J., Klatskin G. Duration of survival in patients with Laennec's cirrhosis: influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. Am J Med 1968, 44:406-420.
4. Graham D.Y., Smith J.L. The course of patients after variceal hemorrhage. Gastroenterology 1981, 80:800-809.
5. Epstein M. Treatment of refractory ascites. N Engl J Med 1989, 321:1675-1677.
6. Gines P., Arroyo V., Vargas V., Planas R., Casafont F., Panes J., et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991, 325:829-835.
7. Richter G.M., Palmaz J.C., Noldge G., Rossle M., Siegerstetter V., Franke M., et al. The transjugular intrahepatic portosystemic stent-shunt. A new nonsurgical percutaneous method. Radiologe 1989, 29:406-411.
8. Garcia-Pagan J.C., Caca K., Bureau C., Laleman W., Appenrodt B., Luca A., Abraldes J.G., Nevens F., Vinel J.P., Mössner J., Bosch J. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010, 362:2370-2379.
9. Chalasani N., Kahi C., Francois F., Pinto A., Marathe A., Bini E.J., et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003, 98:653-659.
10. Thalheimer U., Leandro G., Samonakis D.N., Triantos C.K., Senzolo M., Fung K., et al. TIPS for refractory ascites: a single-centre experience. J Gastroenterol 2009, 44:1089-1095.
11. Petrides A.S., Vogt C., Schulze-Berge D., Matthews D., Strohmeyer G. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 1994, 19:616-627.
12. Greco A.V., Rebuzzi A.G., Altomonte L., Manna R., Bertoli A., Ghirlanda G. Glucose, insulin and somatostatin infusion for the determination of insulin resistance in cirrhosis. Horm Metab Res 1979, 11:547-549.
13. Petrides A.S., Stanley T., Matthews D.E., Vogt C., Bush A.J., Lambeth H. Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity. Hepatology 1998, 28:141-149.
14. Muller M.J., Willmann O., Rieger A., Fenk A., Selberg O., Lautz H.U., et al. Mechanism of insulin resistance associated with liver cirrhosis. Gastroenterology 1992, 102:2033-2041.
15. Gundling F., Schumm-Draeger P.M., Schepp W. Hepatogenous diabetes-diagnostics and treatment. Z Gastroenterol 2009, 47:436-445.
16. Nolte W. Metabolic disturbances in liver cirrhosis: hepatogenous diabetes. Dtsch Med Wochenschr 2010, 135:716.
17. Pazhanivel M., Jayanthi V. Diabetes mellitus and cirrhosis liver. Minerva Gastroenterol Dietol 2010, 56:7-11.
18. Babalik E., Gurmen T., Orhan L., Bulur H., Gulbaran M., Ersanli M., et al. Increased secretion of insulin during oral glucose tolerance test can be a predictor of stent restenosis in non diabetic patients. Catheter Cardiovasc Interv 2003, 58:306-312.
19. Brensing K.A., Raab P., Textor J., Gorich J., Schiedermaier P., Strunk H., et al. Prospective evaluation of a clinical score for 60-day mortality after transjugular intrahepatic portosystemic stent-shunt: Bonn TIPSS early mortality analysis. Eur J Gastroenterol Hepatol 2002, 14:723-731.
20. Rossle M., Haag K., Ochs A., Sellinger M., Noldge G., Perarnau J.M., et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994, 330:165-171.
21. World Health Organization: definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO Consultation. Part 1: diagnosis and classification of Diabetes Mellitus. Geneva, World Health Org, 1999.
22. Montomoli J., Holland-Fischer P., Bianchi G., GrAnbaek H., Vilstrup H., Marchesini G., et al. Body composition changes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis. World J Gastroenterol 2010, 16:348-353.
23. Deschenes M., Somberg K.A. Effect of transjugular intrahepatic portosystemic shunt (TIPS) on glycemic control in cirrhotic patients with diabetes mellitus. Am J Gastroenterol 1998, 93:483.
24. Drucker D.J. The biology of incretin hormones. Cell Metab 2006, 3:153-165.
25. Cavallo-Perin P., Bruno A., Nuccio P., Dallomo A.M., Pagano G., Robecchi A. Lack of increase in insulin resistance after portosystemic surgical shunt in patients with cirrhosis. N Engl J Med 1985, 312:1709-1710.
26. Raddatz D., Rossbach C., Buchwald A., Scholz K.H., Ramadori G., Nolte W. Fasting hyperglucagonemia in patients with transjugular intrahepatic portosystemic shunts (TIPS). Exp Clin Endocrinol Diabetes 2005, 113:268-274.
27. Kaser S., Foger B., Waldenberger P., Nachbaur K., Propst A., Jaschke W., et al. Transjugular intrahepatic portosystemic shunt (TIPS) augments hyperinsulinemia in patients with cirrhosis. J Hepatol 2000, 33:902-906.
28. Stefankova J., Safka V., Fejfar T., Hulek P., Dresslerova I., Krajina A. Effect of transjugular portosystemic shunt on insulin resistance. Vnitr Lek 2002, 48:1017-1024.
29. Holland-Fischer P., Nielsen M.F., Vilstrup H., Tonner-Nielsen D., Mengel A., Schmitz O., et al. Insulin sensitivity and body composition in cirrhosis: changes after TIPS. Am J Physiol Gastrointest Liver Physiol 2010, 299:486-493.